Since HPIP has been shown to activate MAPK/ERK1/2 and AKT in breast cancer and liver cancer cells5, 8, we investigated whether activation of MAPK/ERK1/2 and AKT is responsible for HPIP modulation of CRC cell proliferation, migration and EMT. The gene discussed is AKT1; the disease is breast cancer.